ARD-2128 is a highly potent, orally bioavailable PROTAC (proteolysis-targeting chimera) that degrades the androgen receptor (AR), effectively reducing AR protein levels, suppressing AR-regulated gene expression in tumor tissues, and inhibiting tumor growth without evident toxicity. This compound holds promise for prostate cancer research.
Molecular Weight:
820.37
Purity:
98.80%
CAS Number:
[2222111-87-5]
Formula:
C45H50ClN7O6
Target:
Androgen Receptor|||PROTACs
T39695
* VAT and and shipping costs not included. Errors and price changes excepted
